Literature DB >> 31559547

The optimal indication for FiLaC® is high trans-sphincteric fistula-in-ano: a prospective cohort of 69 consecutive patients.

I Marref1, L Spindler1, M Aubert1, N Lemarchand1, N Fathallah1, E Pommaret1, D Soudan1, H Pillant-le Moult1, E Safa Far1, K Fellous1, E Crochet1, B Mory1, P Benfredj1, V de Parades2.   

Abstract

BACKGROUND: The aim of our study was to prospectively evaluate the effectiveness of the Fistula Laser Closure (FiLaC®) technique in patients at high risk of anal incontinence and to determine the predictors of success and the impact of the procedure on anal continence.
METHODS: A prospective study was conducted on all patients treated with FiLaC® in our department in May 2016-April 2017, because they were at high risk of anal incontinence after fistulotomy, The fistula was considered healed when the internal and external openings were closed and the patient experienced was no pain or leakage.
RESULTS: A total of 69 consecutive patients (34 males) with a median age of 40 years (33-53 years) were included in the study. One patient was lost to follow up. The fistulas were intersphincteric (3%), low (15%) or high (66%) trans-sphincteric, and suprasphincteric (16%). After a median follow-up period of 6.3 months (4.2-9.3), fistula healing was observed in 31 patients (45.6%). In univariate analysis, high trans-sphincteric fistulas (p = 0.007) and age over 50 years (p = 0.034) were significantly associated with healing. In multivariate analysis, only high trans-sphincteric fistulas were a predictive factor of significant success. No new cases of anal incontinence or any worsening in case of pre-existing anal incontinence were observed during follow-up.
CONCLUSIONS: FiLaC® is particularly effective in cases of high trans-sphincteric fistulas (60% cure). This technique seems to be the most promising sphincter-saving technique available for this indication.

Entities:  

Keywords:  Anal fistula; Anal incontinence; Laser FiLaC; Sphincter-sparing technique

Mesh:

Year:  2019        PMID: 31559547     DOI: 10.1007/s10151-019-02077-9

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.781


  18 in total

1.  Fistula-tract Laser Closure (FiLaC™): long-term results and new operative strategies.

Authors:  P Giamundo; L Esercizio; M Geraci; L Tibaldi; M Valente
Journal:  Tech Coloproctol       Date:  2015-02-28       Impact factor: 3.781

2.  A classification of fistula-in-ano.

Authors:  A G Parks; P H Gordon; J D Hardcastle
Journal:  Br J Surg       Date:  1976-01       Impact factor: 6.939

3.  Anal Fistula Laser Closure: the length of fistula is the Achilles' heel.

Authors:  A Lauretta; N Falco; E Stocco; R Bellomo; A Infantino
Journal:  Tech Coloproctol       Date:  2018-12-08       Impact factor: 3.781

4.  Commentary.

Authors:  J Nicholls
Journal:  Colorectal Dis       Date:  2012-09       Impact factor: 3.788

5.  Closure of fistula-in-ano with laser--FiLaC™: an effective novel sphincter-saving procedure for complex disease.

Authors:  P Giamundo; M Geraci; L Tibaldi; M Valente
Journal:  Colorectal Dis       Date:  2014-02       Impact factor: 3.788

Review 6.  Understanding and Treating Supralevator Fistula-in-Ano: MRI Analysis of 51 Cases and a Review of Literature.

Authors:  Pankaj Garg
Journal:  Dis Colon Rectum       Date:  2018-05       Impact factor: 4.585

7.  Practice parameters for the treatment of perianal abscess and fistula-in-ano (revised).

Authors:  Mark H Whiteford; John Kilkenny; Neil Hyman; W Donald Buie; Jeffrey Cohen; Charles Orsay; Gary Dunn; W Brian Perry; C Neal Ellis; Jan Rakinic; Sharon Gregorcyk; Paul Shellito; Richard Nelson; Joe J Tjandra; Graham Newstead
Journal:  Dis Colon Rectum       Date:  2005-07       Impact factor: 4.585

8.  Fibrin glue-antibiotic mixture in the treatment of anal fistulae: experience with 69 cases.

Authors:  L Patrlj; B Kocman; M Martinac; S Jadrijevic; T Sosa; B Sebecic; B Brkljacic
Journal:  Dig Surg       Date:  2000       Impact factor: 2.588

9.  The use of fibrin glue in the treatment of fistula-in-ano: a prospective study.

Authors:  Göktürk Maralcan; Ilyas Başkonuş; Necdet Aybasti; Avni Gökalp
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

10.  Five years of experience with the FiLaC™ laser for fistula-in-ano management: long-term follow-up from a single institution.

Authors:  A Wilhelm; A Fiebig; M Krawczak
Journal:  Tech Coloproctol       Date:  2017-03-07       Impact factor: 3.781

View more
  6 in total

Review 1.  Efficacy and safety of FiLaC™ for perianal fistulizing Crohn's disease: a systematic review and meta-analysis.

Authors:  D Cao; W Li; X Wang; Y Ji; Z Cui
Journal:  Tech Coloproctol       Date:  2022-08-12       Impact factor: 3.699

Review 2.  Comprehensive literature review of the applications of surgical laser in benign anal conditions.

Authors:  Ahmed Hossam Elfallal; Mohammad Fathy; Samy Abbas Elbaz; Sameh Hany Emile
Journal:  Lasers Med Sci       Date:  2022-05-23       Impact factor: 2.555

Review 3.  Video-assisted anal fistula treatment for complex anorectal fistulas in adults: a systematic review and meta-analysis.

Authors:  Z Tian; Y L Li; S J Nan; W C Xiu; Y Q Wang
Journal:  Tech Coloproctol       Date:  2022-03-28       Impact factor: 3.699

4.  Sphincter-saving therapy for fistula-in-ano: long-term follow-up after FiLaC®.

Authors:  A Wolicki; P Jäger; T Deska; M Senkal
Journal:  Tech Coloproctol       Date:  2020-08-31       Impact factor: 3.781

5.  FiLaC® and Crohn's disease perianal fistulas: a pilot study of 20 consecutive patients.

Authors:  A Alam; F Lin; N Fathallah; E Pommaret; M Aubert; N Lemarchand; L Abbes; L Spindler; A Portal; V de Parades
Journal:  Tech Coloproctol       Date:  2019-12-31       Impact factor: 3.781

Review 6.  Emerging Data on Fistula Laser Closure (FiLaC) for the Treatment of Perianal Fistulas; Patient Selection and Outcomes.

Authors:  Samuel O Adegbola; Kapil Sahnan; Phillip Tozer; Janindra Warusavitarne
Journal:  Clin Exp Gastroenterol       Date:  2021-12-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.